Sunitinib-induced microangiopathic hemolytic anemia with fatal outcome

American Journal of Therapeutics

Volumn 19, Issue 4, 2012, Pages

  Talebi, Tony N ^a   Stefanovic, Alexandra ^a   Merchan, Jaime ^a   Lian, Eric ^a   Silva, Orlando ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

microangiopathic hemolytic anemia; renal failure; sunitinib; Sutent; thrombocytopenia

Indexed keywords

CREATININE; LACTATE DEHYDROGENASE; SUNITINIB;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DEHYDRATION; DRUG FATALITY; FEVER; HEART ARREST; HUMAN; KIDNEY CARCINOMA; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; MALAISE; MALE; NAUSEA; NEPHRECTOMY; PANCREAS METASTASIS; PANCREAS RESECTION; PRIORITY JOURNAL; PROTEINURIA; SKIN TURGOR; SPLENECTOMY; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUMOR VOLUME; WEAKNESS; XEROSTOMIA;

AGED; ANGIOGENESIS INHIBITORS; CARCINOMA, RENAL CELL; FATAL OUTCOME; HUMANS; INDOLES; KIDNEY NEOPLASMS; MALE; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; PYRROLES; RENAL DIALYSIS;

EID: 84863701899     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181eefe8b     Document Type: Article

References (5)

1. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007;356:115-124.
2. Rini BI, Tamaskar I, Shaheen P, et al. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst. 2007;99:81-83.
3. Frangie C, Lefaucheur C, Medioni J, et al. Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma. Lancet Oncol. 2007;8:177-178.
4. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358:1129-1136.
5. Hohenstein B, Braun A, Amann KU, et al. A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy. Nephrol Dial Transplant. 2008; 23:1144-1156.